Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
BioCity will present the late-breaking clinical trial data of its ETA selective antagonist SC0062 at the American Society of Nephrology (ASN) 2024 with simultaneous publication of the trial data in the Journal of the American Society of Nephrology (JASN) 2024-10-14 15:38
Zhejiang Taimei Medical Technology Co., Ltd. Is Now Listed on HKEX 2024-10-14 10:18
Modern Meadow Appoints David Williamson as CEO 2024-10-14 09:00
Akeso Secures $250 Million USD to Propel Global Expansion of Its Innovative Drug Pipeline 2024-10-13 20:27
Sunvozertinib Granted Breakthrough Therapy Designation by China CDE for the First-Line Treatment of Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations 2024-10-13 16:04
Ailux Biologics, a Division of XtalPi, Enters into a License Agreement with Janssen Biotech on Biologics AI Platform 2024-10-12 16:57
Baird Medical Announces Preliminary Financial Results for the Six Months Ended June 30, 2024 2024-10-11 20:00
Delegation of International Communication Experts and Foreign Media Outlets Visits Emerging Industry Enterprises in Zhongshan, Guangdong Province 2024-10-11 00:53
Datasea Pre-announces Estimated First Quarter 2025 Fiscal Year Revenue of approximately $22.7 Million, Up 230% Year-Over-Year 2024-10-10 21:45
111 Inc. Expands National Supply Chain Network with New Fulfillment Centers across South and Central China 2024-10-10 18:02
Harbour BioMed Announces Publication of the Phase I Study Results for Porustobart in Combination with Toripalimab in Advanced Melanoma and Other Solid Tumors 2024-10-10 11:04
Arbele Announces Strategic Collaborations on AI Precision Oncology and Manufacturing to Advance CDH17-Targeted Immunotherapeutics 2024-10-09 23:00
Baird Medical Lists in the U.S. on the Nasdaq Exchange 2024-10-09 20:30
Nona Biosciences Enters Strategic Collaboration with OverT Bio to Advance Next-Generation Cell Therapies for Solid Tumors 2024-10-09 20:00
Alpha Fusion Accelerates Astatine-based Drug Discovery with Series B Funding 2024-10-09 15:23
Joint Venture Company Established for Incubation of Early Drug Discovery Programs; Investment from Takeda, Astellas and Sumitomo Mitsui Banking 2024-10-09 10:00
Rege Nephro Co., Ltd. Successfully Completes Series B Funding to Accelerate Kidney Disease Therapy Trials 2024-10-09 07:39
Baird Medical to Participate in Roth's 3rd Annual Healthcare Opportunities Conference 2024-10-09 04:30
Korea's SK bioscience Acquires Stake in U.S. Biotech Fina Biosolutions 2024-10-08 20:00
MicuRx Pharmaceuticals Announces Promising Results from MRX-5 Study for Treating Mycobacterium abscessus Infections 2024-10-08 13:38
1 7 8 9 10 11 431